These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23429710)

  • 61. 28-Year-Old Woman With Severe Generalized Abdominal Pain.
    Tatari MM; McCain JD; Cowdell JC
    Mayo Clin Proc; 2019 Jul; 94(7):1334-1338. PubMed ID: 31272576
    [No Abstract]   [Full Text] [Related]  

  • 62. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Same-day initiation of hormonal contraceptives.
    Scott T
    Am Fam Physician; 2009 Oct; 80(7):690. PubMed ID: 19817338
    [No Abstract]   [Full Text] [Related]  

  • 64. Counseling teens and young women on Depo-Provera.
    Tonelli M; Nicoletti A
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):297-8. PubMed ID: 16171737
    [No Abstract]   [Full Text] [Related]  

  • 65. Sale and provision of injectable contraceptives in drug shops in developing countries: conclusions from a technical consultation.
    Stanback J; Lebetkin E; Orr T; Malarcher S;
    Contraception; 2015 Feb; 91(2):93-6. PubMed ID: 25604899
    [No Abstract]   [Full Text] [Related]  

  • 66. Broadening the debate over HIV and hormonal contraception.
    Colvin CJ; Harrison A
    Lancet Infect Dis; 2015 Feb; 15(2):135-6. PubMed ID: 25578824
    [No Abstract]   [Full Text] [Related]  

  • 67. The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor.
    Tomasicchio M; Davids M; Pooran A; Theron G; Smith L; Semple L; Meldau R; Hapgood JP; Dheda K
    J Infect Dis; 2019 Apr; 219(8):1329-1337. PubMed ID: 30452655
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Research on hormonal contraception and HIV.
    Gollub EL; Stein Z
    Lancet; 2014 Jan; 383(9914):304-5. PubMed ID: 24461117
    [No Abstract]   [Full Text] [Related]  

  • 69. Research on hormonal contraception and HIV.
    Cates W;
    Lancet; 2014 Jan; 383(9914):303-4. PubMed ID: 24461116
    [No Abstract]   [Full Text] [Related]  

  • 70. Research on hormonal contraception and HIV.
    Redd AD
    Lancet; 2014 Jan; 383(9914):305. PubMed ID: 24461118
    [No Abstract]   [Full Text] [Related]  

  • 71. Transcriptional response of vaginal epithelial cells to medroxyprogesterone acetate treatment results in decreased barrier integrity.
    Woods MW; Zahoor MA; Lam J; Bagri P; Dupont H; Verschoor CP; Nazli A; Kaushic C
    J Reprod Immunol; 2021 Feb; 143():103253. PubMed ID: 33285485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
    Seidman D; Averbach S; Smith-McCune K; Darney P
    Lancet HIV; 2015 Sep; 2(9):e365-6. PubMed ID: 26423545
    [No Abstract]   [Full Text] [Related]  

  • 73. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
    Schooling CM
    Lancet HIV; 2015 Sep; 2(9):e366. PubMed ID: 26423548
    [No Abstract]   [Full Text] [Related]  

  • 74. The injectable contraceptive: present and future trends.
    Koetsawang S
    Ann N Y Acad Sci; 1991; 626():30-42. PubMed ID: 1829341
    [No Abstract]   [Full Text] [Related]  

  • 75. Research on hormonal contraception and HIV - Authors' reply.
    Ralph L; McCoy S; Hallett T; Padian N
    Lancet; 2014 Jan; 383(9914):305-6. PubMed ID: 24461119
    [No Abstract]   [Full Text] [Related]  

  • 76. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.
    Noguchi LM; Richardson BA; Balkus JE; Marrazzo JM
    Lancet HIV; 2015 Sep; 2(9):e366-7. PubMed ID: 26423547
    [No Abstract]   [Full Text] [Related]  

  • 77. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.
    Jones HE; van de Wijgert JH
    Lancet HIV; 2015 Sep; 2(9):e367. PubMed ID: 26423549
    [No Abstract]   [Full Text] [Related]  

  • 78. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response.
    Nene Z; Hofmeyr GJ; Patel M; Panday M; Rees H; Makua M; Pillay Y
    S Afr Med J; 2018 Jul; 108(8):629-631. PubMed ID: 30182875
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk.
    Irvin SC; Herold BC
    PLoS One; 2015; 10(3):e0121135. PubMed ID: 25798593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Next steps for research on hormonal contraception and HIV.
    Ralph LJ; McCoy SI; Hallett T; Padian N
    Lancet; 2013 Nov; 382(9903):1467-9. PubMed ID: 23810224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.